胸腺嘧啶核苷磷酸化酶(TP)重組蛋白
Recombinant Thymidine Phosphorylase (TP)
TYMP; PDECGF; ECGF1; MNGIE; TP; HPD-ECGF; TdRPase; Platelet-Derived Endothelial Cell Growth Factor; Gliostatin
- 編號RPA948Ra01
- 物種Rattus norvegicus (Rat,大鼠)相同的名稱,不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細(xì)胞定位細(xì)胞質(zhì)
- 預(yù)測分子量57.2kDa
- 實(shí)際分子量57kDa(差異分析請參閱說明書)
- 片段與標(biāo)簽Ile33~Ala290 with N-terminal His and GST Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點(diǎn)5.9
- 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請參見活性蛋白。 - 下載英文說明書 中文說明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價(jià)格¥ 1272 ¥ 3180¥ 6360¥ 19080¥ 47700
- 欲了解實(shí)際交易價(jià)格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
序列

用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個(gè)月,-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Rattus norvegicus (Rat,大鼠) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPA948Ra01 | 胸腺嘧啶核苷磷酸化酶(TP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA948Ra01 | 胸腺嘧啶核苷磷酸化酶(TP)多克隆抗體 | WB; IHC; ICC; IP. |
LAA948Ra81 | 胸腺嘧啶核苷磷酸化酶(TP)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
LAA948Ra71 | 胸腺嘧啶核苷磷酸化酶(TP)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Eur J Obstet Gynecol Reprod Biol. | Profiling of selected angiogenesis-related genes in proliferative eutopic endometrium of women with endometriosis[Pubmed: 24188612] |
PLoS One. | Liver as a source for thymidine phosphorylase replacement in mitochondrial neurogastrointestinal encephalomyopathy[Pubmed:24802030] |
BMC Clinical Pathology | Thymidine phosphorylase expression is associated with time to progression in patients with metastatic colorectal cancer[Pubmed:24936150] |
Oncotarget | Capecitabine reverses tumor escape from anti-VEGF through the eliminating CD11bhigh/Gr1high myeloid cells[Pubmed:29707135] |
Clinica?Chimica?Acta | Prognostic significance of serum translocator protein in patients with traumatic brain injury[Pubmed: 30385279] |
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH | Usefulness of postoperative serum translocator protein as a predictive marker for delirium after breast cancer surgery in elderly women[Pubmed: 32529881] |
Bioengineering & Translational Medicine | Targeting thymidine phosphorylase as a potential therapy for bone loss associated periprosthetic osteolysis[] |